Home/ Stocks/ BVS

Bioventus Inc. Class A Common Stock

BVS XNAS

$10.50 -0.53 (-5.02%) ▼ 15-min delayed

Open

$10.93

High

$10.93

Low

$10.33

Volume

360.6K

Market Cap

$711.35M

About Bioventus Inc. Class A Common Stock

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 940 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$132.09M	$3.95M	$0.05
FY 2025	$568.09M	$27.27M	$0.34
Q3 2025	$138.65M	$4.01M	$0.05
Q2 2025	$147.66M	$9.27M	$0.11

Earnings & Analyst Ratings

Next Earnings: Tue, Aug 4, 2026

Calendar →

Related Market News

No specific coverage for BVS yet. Check out our latest market news or earnings calendar.

Get BVS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Bioventus Inc. Class A Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.